# Safety, Toxicity and MTD of One Intravenous IV Injection of Donor CTLs Specific for CMV and Adenovirus

> **NCT00880789** · PHASE1 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 9 (actual)

## Conditions studied

- Cytomegalovirus Infection
- Adenovirus Infection

## Interventions

- **BIOLOGICAL:** CMV/AdV specific T cells

## Key facts

- **NCT ID:** NCT00880789
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2013-08
- **Final completion:** 2014-06
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2014-10-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00880789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00880789, "Safety, Toxicity and MTD of One Intravenous IV Injection of Donor CTLs Specific for CMV and Adenovirus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00880789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*